Update of human spinal cord reirradiation tolerance based on additional data from 38 patients.
Nieder C, Grosu AL, Andratschke NH, Molls M.
Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1446-9. doi: 10.1016/j.ijrobp.2006.07.1383. Epub 2006 Nov 2.
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
Maron MS, Masri A, Choudhury L, Olivotto I, Saberi S, Wang A, Garcia-Pavia P, Lakdawala NK, Nagueh SF, Rader F, Tower-Rader A, Turer AT, Coats C, Fifer MA, Owens A, Solomon SD, Watkins H, Barriales-Villa R, Kramer CM, Wong TC, Paige SL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Abraham T; REDWOOD-HCM Steering Committee and Investigators.
J Am Coll Cardiol. 2023 Jan 3;81(1):34-45. doi: 10.1016/j.jacc.2022.10.020.
Lung SBRT: Dose gradient optimization based on target size.
Benner K, Roper J, Kesarwala AH, Fehrs S, Schreibmann E, Luca K.
Med Dosim. 2024 Sep 10:S0958-3947(24)00044-X. doi: 10.1016/j.meddos.2024.08.003. Online ahead of print.
A method to improve dose gradient for robotic radiosurgery.
Li T, Ozhasoglu C, Burton S, Flickinger J, Heron DE, Huq MS.
J Appl Clin Med Phys. 2015 Nov 8;16(6):333-339. doi: 10.1120/jacmp.v16i6.5748.
Appropriateness of Dose Attenuation Margin Outside the Gross Tumor Volume (GTV) in Volumetric-Modulated Arc-Based Radiosurgery for Brain Metastasis With the Steepest Dose Gradient Outside the GTV and Biologically Effective Dose 80 Gy to GTV Boundary.
Ohtakara K, Suzuki K.
Cureus. 2024 Jun 20;16(6):e62784. doi: 10.7759/cureus.62784. eCollection 2024 Jun.
The superficially averaged dose gradient at the target volume's boundary: A two-dimensional formulation and solution of anisotropic dose gradient problems.
Wösle M.
Z Med Phys. 2020 Feb;30(1):70-86. doi: 10.1016/j.zemedi.2019.09.002. Epub 2019 Dec 14.
The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer.
Tanaka N.
Prostate Int. 2023 Sep;11(3):127-133. doi: 10.1016/j.prnil.2023.01.004. Epub 2023 Feb 6.
Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline.
Hattori N, Kabata D, Asada S, Kanda T, Nomura T, Shintani A, Mori A.
PLoS One. 2023 Dec 22;18(12):e0269969. doi: 10.1371/journal.pone.0269969. eCollection 2023.
Toward 3D dose verification of an electronic brachytherapy source with a plastic scintillation detector.
Georgi P, Kertzscher G, Nyvang L, Šolc J, Schneider T, Tanderup K, Johansen JG.
Med Phys. 2022 May;49(5):3432-3443. doi: 10.1002/mp.15568. Epub 2022 Mar 3.
Development of a bio-relevant pH gradient dissolution method for a high-dose, weakly acidic drug, its optimization and IVIVC in Wistar rats: a case study of magnesium orotate dihydrate.
Verma H, Garg R.
Magnes Res. 2022 Jul 1;35(3):88-95. doi: 10.1684/mrh.2022.0505.
